{"id":"W3138063460","doi":"10.1007/s00277-021-04465-4","title":"Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"Incyte; Daiichi Sankyo Europe; Agios Pharmaceuticals; Jazz Pharmaceuticals; Celgene; Astellas Pharma; Ariad Pharmaceuticals; Alexion Pharmaceuticals; Servier; Pfizer; Amgen","keywords":"Medicine; Cytarabine; Internal medicine; Myeloid leukemia; Hazard ratio; Leukemia; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004236921,0.0009676997,0.002294726,0.0003528942,0.0003308002,0.001365261,0.0006299642,0.001200929,0.002192442],"category_scores_gemma":[0.002578347,0.0003333767,0.002884188,0.0004961932,0.0007659905,0.001009735,0.0005022321,0.00274833,0.0003885112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007896977,"about_ca_system_score_gemma":0.0009863263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003756738,"about_ca_topic_score_gemma":0.001232892,"domain_scores_codex":[0.9983316,0.001186675,0.00008475347,0.0001672056,0.00009288253,0.0001369245],"domain_scores_gemma":[0.9975888,0.0007846451,0.0006049212,0.0002124561,0.0001108366,0.0006984174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9631967,0.003517319,0.002898854,0.0004411781,0.00242061,0.000041601,0.00004448352,0.0004960134,0.002746365,0.00009986168,0.0006271678,0.02347001],"study_design_scores_gemma":[0.8508423,0.1320858,0.0116175,0.00007259546,0.0020241,0.00009696963,0.00003932496,0.001066499,0.0006821735,0.0003065368,0.001137555,0.00002866078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850594,0.0104281,0.0006793376,0.0006966066,0.0002395031,0.0008455146,0.0006959343,0.00005947399,0.001295999],"genre_scores_gemma":[0.9914231,0.002846071,0.0008668602,0.0009624374,0.0003410746,0.001104871,0.001554834,0.00001596708,0.0008849021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004236921,"threshold_uncertainty_score":0.02240723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03271105453675983,"score_gpt":0.3778921484179776,"score_spread":0.3451810938812178,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}